Difficulty: Medium
Average Score: 70%
Practice
An LPN attending to chronic hypertensive elderly patients at the local skilled nursing facility should remember that use of beta adrenergic blockers can negate effects of
Correct answer
A
Rationale
In this scenario, the correct answer is A) Beta 2 adrenergic agonists. Beta adrenergic blockers (such as propranolol, metoprolol) are commonly used in the management of hypertension in elderly patients. These medications block the beta receptors which can lead to decreased heart rate and blood pressure.
When a beta adrenergic blocker is used, it can negate the effects of beta 2 adrenergic agonists (such as albuterol, salmeterol) which are commonly used as bronchodilators in patients with respiratory conditions like asthma or COPD. Beta 2 adrenergic agonists work by dilating the airways to improve breathing, but if beta blockers are present, they can counteract these effects by blocking the beta receptors that the beta 2 agonists would normally act on.
Option B) Bronchodilators is incorrect because not all bronchodilators are beta 2 adrenergic agonists. There are other classes of bronchodilators like anticholinergics (ipratropium) and methylxanthines (theophylline) which are not affected by beta blockers.
Option C) Both is incorrect because beta blockers specifically negate the effects of beta 2 adrenergic agonists, not all bronchodilators.
Option D) Neither is incorrect as beta blockers do have an impact on the effectiveness of beta 2 adrenergic agonists.
Understanding these interactions is crucial for healthcare providers to ensure they are providing safe and effective care to their patients, especially in elderly populations with multiple comorbidities like hypertension and respiratory conditions. It is important for LPNs working in skilled nursing facilities to be aware of these interactions to prevent potential adverse outcomes in their patients.
When a beta adrenergic blocker is used, it can negate the effects of beta 2 adrenergic agonists (such as albuterol, salmeterol) which are commonly used as bronchodilators in patients with respiratory conditions like asthma or COPD. Beta 2 adrenergic agonists work by dilating the airways to improve breathing, but if beta blockers are present, they can counteract these effects by blocking the beta receptors that the beta 2 agonists would normally act on.
Option B) Bronchodilators is incorrect because not all bronchodilators are beta 2 adrenergic agonists. There are other classes of bronchodilators like anticholinergics (ipratropium) and methylxanthines (theophylline) which are not affected by beta blockers.
Option C) Both is incorrect because beta blockers specifically negate the effects of beta 2 adrenergic agonists, not all bronchodilators.
Option D) Neither is incorrect as beta blockers do have an impact on the effectiveness of beta 2 adrenergic agonists.
Understanding these interactions is crucial for healthcare providers to ensure they are providing safe and effective care to their patients, especially in elderly populations with multiple comorbidities like hypertension and respiratory conditions. It is important for LPNs working in skilled nursing facilities to be aware of these interactions to prevent potential adverse outcomes in their patients.